Rifabutin is a rifamycin-class antibiotic primarily prescribed to prevent and treat mycobacterial infections, including tuberculosis and Mycobacterium avium complex disease in immunocompromised patients.… Read more



























Rifabutin is a rifamycin-class antibiotic primarily prescribed to prevent and treat mycobacterial infections, including tuberculosis and Mycobacterium avium complex disease in immunocompromised patients. It functions by inhibiting bacterial DNA-dependent RNA polymerase, thereby disrupting essential bacterial processes. To support stringent pharmaceutical analysis, this category provides a comprehensive selection of reference standards. These include the Rifabutin API, its pharmacopeial and non-pharmacopeial impurities—such as epimers, N-nitroso derivatives, and deacetylation products—and various stable isotope labelled compounds. Pharmaceutical laboratories utilize these materials for reliable impurity profiling, method validation, and routine quality control, ensuring the accuracy of quantitative and qualitative assessments throughout the drug development and manufacturing lifecycle.